The landscape of dementia diagnosis has progressed considerably with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology yrs before signs emerge. Although these technological advancements represent exceptional development in being familiar with neurodegenerative